{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:21:45Z","timestamp":1787023305844,"version":"build-2736575974"},"reference-count":25,"publisher":"Bioscientifica","issue":"2","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic endocrine tumors (PETs) are uncommon and the genetic alterations in these indolent tumors are not well characterized. Chromosomal imbalances are frequent in tumors but PETs have not been studied by high-density single nucleotide polymorphism (SNP) array. We used genome-wide high-density SNP array analysis to detect copy number alterations using matched tumor and non-neoplastic tissue samples from 15 patients with PETs. In our study, whole or partial loss of chromosomes 1, 3, 11, 22 was present in 40, 47, 53, 40% of tumors respectively, and gain of chromosomes 5, 7, 12, 14, 17, and 20 was present in 47, 60, 47, 53, 53, and 47% of tumors respectively. One tumor had loss of heterozygosity of chromosome 3 and another of chromosome 22 without copy number alterations, suggesting uniparental disomy due to non-disjunction and deletion or to chromosomal recombination. Chromosomal aberrations of the autosomal chromosomes were correlated with chromosomal loss or gain of other chromosomes (r&amp;gt;0.5, P&amp;lt;0.5). About 60% of PETs had high allelic imbalances (AI) defined by more than four chromosomal aberrations, and 40% of tumors had low AI. The PETs with high AI were larger: the mean tumor size with high AI was 5.4 \u00b1 3.1 cm compared with 2.3 \u00b1 1.3 cm for low AI (P = 0.03). Our study shows that genome-wide allelotyping is a powerful new tool for the analysis of AI in PETs.<\/jats:p>","DOI":"10.1677\/erc-06-0090","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T11:22:00Z","timestamp":1184671320000},"page":"483-492","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":31,"title":["Allelic alterations in pancreatic endocrine tumors identified by genome-wide single nucleotide polymorphism analysis"],"prefix":"10.1530","volume":"14","author":[{"given":"Yasuhiko","family":"Nagano","sequence":"first","affiliation":[{"name":"Department of Pathology, MD Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Box 85, Houston, Texas 77030-4095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Ha","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, MD Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Box 85, Houston, Texas 77030-4095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Departments of Biostatistics and Applied Mathematics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A","family":"White","sequence":"additional","affiliation":[{"name":"Department of Pathology, MD Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Box 85, Houston, Texas 77030-4095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Yao","sequence":"additional","affiliation":[{"name":"2Gastrointestinal Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley R","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Department of Pathology, MD Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Box 85, Houston, Texas 77030-4095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Rashid","sequence":"additional","affiliation":[{"name":"Department of Pathology, MD Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Box 85, Houston, Texas 77030-4095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070906014209200_AGATHANGGELOU-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Agathanggelou\n            A\n          , Honorio S, Macartney D, Martinez A, Dallol A, Rader J, Fullerwood P, Chauhan A, Walker R, Shaw JA et al.2001 Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. \nOncogene201509\u20131518.","DOI":"10.1038\/sj.onc.1204175"},{"key":"2026070906014209200_BARTSCH-ETAL-2000","unstructured":"Bartsch\n            DK\n          , Kersting M, Wild A, Ramaswamy A, Gerdes B, Schuermann M, Simon B & Rothmund M \n2000 Low frequency of p16 (INK4a) alterations in insulinomas. \nDigestion62171\u2013177."},{"key":"2026070906014209200_BUCHANAN-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Buchanan\n            KD\n          , Johnston CF, O\u2019Hare M, Ardill JE, Shaw C, Collins JS, Watson RG, Atkinson AB, Hadden DR, Kennedy TL et al.1986 Neuroendocrine tumors: a European view. \nAmerican Journal of Medicine8114\u201322.","DOI":"10.1016\/0002-9343(86)90581-4"},{"key":"2026070906014209200_CHAN-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Chan\n            AO\n          , Kim SG, Bedeir A, Issa JP, Hamilton SR & Rashid A \n2003 CpG island methylation in carcinoid and pancreatic endocrine tumors. \nOncogene22924\u2013934.","DOI":"10.1038\/sj.onc.1206123"},{"key":"2026070906014209200_CHUNG-ETAL-1998","unstructured":"Chung\n            DC\n          , Brown SB, Graeme-Cook F, Tillotson LG, Warshaw AL, Jensen RT & Arnold A \n1998 Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. \nCancer Research583706\u20133711."},{"key":"2026070906014209200_DREIJERINK-ETAL-2001","unstructured":"Dreijerink\n            K\n          , Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD et al.2001 The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. \nPNAS987504\u20137509."},{"key":"2026070906014209200_GORTZ-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Go\u0308rtz\n            B\n          , Roth J, Krahenmann A, Krijger RR, Muletta-Feurer S, Rutimann K, Saremaslani P, Speel EJ, Heitz PU & Komminoth P \n1999 Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. \nAmerican Journal of Pathology154429\u2013436.","DOI":"10.1016\/S0002-9440(10)65289-3"},{"key":"2026070906014209200_HESSMAN-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Hessman\n            O\n          , Skogseid B, Westin G & Akerstrom G \n2001 Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors. \nJournal of Clinical Endocrinology and Metabolism861355\u20131361.","DOI":"10.1210\/jc.86.3.1355"},{"key":"2026070906014209200_HOUSE-ETAL-2003","doi-asserted-by":"crossref","unstructured":"House\n            MG\n          , Herman JG, Guo MZ, Hooker CM, Schulick RD, Lillemoe KD, Cameron JL, Hruban RH, Maitra A & Yeo CJ \n2003 Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. \nAnnals of Surgery238423\u2013431.","DOI":"10.1097\/01.sla.0000086659.49569.9e"},{"key":"2026070906014209200_IRVING-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Irving\n            JAE\n          , Bloodworth L, Bown NP, Case MC, Hogarth LA & Hall GA \n2005 Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis. \nCancer Research653053\u20133058.","DOI":"10.1158\/0008-5472.CAN-04-2604"},{"key":"2026070906014209200_LIU-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Liu\n            L\n          , Broaddus RR, Yao JC, Xie S, White JA, Wu TT, Hamilton SR & Rashid A \n2005 Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. \nModern Pathology181632\u20131640.","DOI":"10.1038\/modpathol.3800490"},{"key":"2026070906014209200_LU-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Lu\n            Y-J\n          , Yang J, Noel E, Skoulakis S, Chaplin T, Raghaven M, Purkis T, McIntyre A, Kudahetti SC, Maase M et al.2005 Association between large-scale genomic homozygosity without chromosomal loss and nonseminomatous germ cell tumor development. \nCancer Research659137\u20139141.","DOI":"10.1158\/0008-5472.CAN-05-1697"},{"key":"2026070906014209200_LUBOMIERSKI-ETAL-2001","unstructured":"Lubomierski\n            N\n          , Kersting M, Bert T, Muench K, Wulbrand U, Schuermann M, Bartsch D & Simon B \n2001 Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroentero-pancreatic tumors. \nCancer Research615905\u20135910."},{"key":"2026070906014209200_MATSUZAKI-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Matsuzaki\n            H\n          , Dong S, Loi H, Di X, Liu G, Hubbell E, Law J, Berntsen T, Chadha M, Hui H et al.2004 Genotyping over 100 000 SNPs on a pair of oligonucleotide arrays. \nNature Methods1109\u2013111.","DOI":"10.1038\/nmeth718"},{"key":"2026070906014209200_NANNYA-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Nannya\n            Y\n          , Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, Kurokawa M, Chiba S, Bailey DK, Kennedy GC et al.2005 A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. \nCancer Research656071\u20136079.","DOI":"10.1158\/0008-5472.CAN-05-0465"},{"key":"2026070906014209200_RIGAUD-ETAL-2001","unstructured":"Rigaud\n            G\n          , Missiaglia E, Moore PS, Zamboni G, Falconi M, Talamini G, Pesci A, Baron A, Lissandrini D, Rindi G et al.2001 High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. \nCancer Research61285\u2013292."},{"key":"2026070906014209200_SERRANO-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Serrano\n            J\n          , Goebel SU, Peghini PL, Lubensky IA, Gibril F & Jensen RT \n2000 Alterations in the p16INK4a\/CDKN2A tumor suppressor gene in gastrinomas. \nJournal of Clinical Endocrinology and Metabolism854146\u20134156.","DOI":"10.1210\/jcem.85.11.6970"},{"key":"2026070906014209200_SPEEL-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Speel\n            EJ\n          , Richter J, Moch H, Egenter C, Saremaslani P, Rutimann K, Zhao J, Barghorn A, Roth J, Heitz PU et al.1999 Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. \nAmerican Journal of Pathology1551787\u20131794.","DOI":"10.1016\/S0002-9440(10)65495-8"},{"key":"2026070906014209200_SPEEL-ETAL-2001","unstructured":"Speel\n            EJM\n          , Scheidweiler AF, Zhao J, Matter C, Saremaslani P, Roth J, Heitz PU & Komminoth P \n2001 Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas. \nCancer Research615186\u20135192."},{"key":"2026070906014209200_TEH-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Teh\n            MT\n          , Blaydon D, Chaplin T, Foot NJ, Skoulakis S, Raghavan M, Harwood CA, Proby CM, Philpott MP, Young BD et al.2005 Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. \nCancer Research658597\u20138603.","DOI":"10.1158\/0008-5472.CAN-05-0842"},{"key":"2026070906014209200_TERRIS-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Terris\n            B\n          , Meddeb M, Marchio A, Danglot G, Flejou JF, Belghiti J, Ruszniewski P & Bernheim A \n1998 Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system. \nGenes, Chromosomes and Cancer2250\u201356.","DOI":"10.1002\/(SICI)1098-2264(199805)22:1<50::AID-GCC7>3.0.CO;2-6"},{"key":"2026070906014209200_TONNIES-ETAL-2001","doi-asserted-by":"crossref","unstructured":"To\u0308nnies\n            H\n          , Toliat MR, Ramel C, Pape UF, Neitzel H, Berger W & Wiedenmann B \n2001 Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridization. \nGut48536\u2013541.","DOI":"10.1136\/gut.48.4.536"},{"key":"2026070906014209200_WANG-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Wang\n            GG\n          , Yao JC, Worah S, White JA, Luna R, Wu TT, Hamilton SR & Rashid A \n2005 Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors. \nModern Pathology181079\u20131087.","DOI":"10.1038\/modpathol.3800389"},{"key":"2026070906014209200_ZHAO-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Zhao\n            J\n          , Moch H, Scheidweiler AF, Baer A, Schaffar AA, Speel EJM, Roth J, Heitz PU & Komminoth P \n2001 Genomic imbalances in the progression of endocrine pancreatic tumors. \nGenes, Chromosomes and Cancer32364\u2013372.","DOI":"10.1002\/gcc.1201"},{"key":"2026070906014209200_ZHAO-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Zhao\n            X\n          , Li C, Paez JG, Chin K, Janne PA, Chen TH, Girard L, Minna J, Christiani D, Leo J et al.2004 An integrated view of copy number and allelic alterations in the cancer genome using single nucletide polymorphism arrays. \nCancer Research643060\u20133071.","DOI":"10.1158\/0008-5472.CAN-03-3308"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/14\/2\/0140483.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/14\/2\/483\/150578\/0140483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/14\/2\/483\/150578\/0140483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:01:58Z","timestamp":1783591318000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/14\/2\/483\/26782\/Allelic-alterations-in-pancreatic-endocrine-tumors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc-06-0090","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}